This study is looking at different ways of holding your breath during radiotherapy for breast cancer, and at the position you lay on the radiotherapy couch. These techniques may lower the risk of
long term side effects to the heart.
Having radiotherapy after surgery for breast cancer can help stop the cancer coming back. Your team will take great care to plan your radiotherapy so that the beam reaches as little surrounding tissue as possible, because this type of exposure to radiation can cause side effects months, or even years after treatment. The affected tissue may include your lung, ribs and, if the cancer is in your left breast, your heart.
Doctors want to find ways of lowering the risk of side effects as much as possible. This study is looking at improving radiotherapy treatment for women with left sided breast cancer, which has a greater risk of long term side effects to the heart. Holding your breath in a particular way may reduce the amount of heart tissue exposed to X-rays. Women are taught to hold their breath for about 20 seconds while they have radiotherapy. Breathing in pulls the heart away from the radiotherapy beam. Also, lying face down (prone) on the radiotherapy couch rather than on your back may help to reduce the amount of heart tissue exposed to X-rays in larger breasted women. But doctors do not know whether a certain breathing technique, or position, works best. The aim of this study is to find out if one method is better than the other at reducing radiation to the heart tissue.
For more information on this trial go to :
Warwick Clinical Trials
12 members of ICPV attended a residential Clinical Trials Course at the University of Warwick from 17th to 19th April 2018. The course was run by Professor Janet Dunn and covered the different types of studies undertaken; consent; trial design; statistics and bringing a drug to market. One of the highlights of the course was a visit to the West Midlands Surgical Training Centre where delegates had the privilege of seeing real body parts and having basic anatomy explained to them by the team. The delegates would like to thank Professor Janet Dunn for her outstanding enthusiasm and for her generous hospitality.
Open letter calling on Government to prioritise interests of cancer patients in Brexit negotiations
ICPV have come together with 18 other cancer charities to put our names to an open letter to Government. We want Government to prioritise seeking continued alignment with the EU drug licensing
process and Clinical Trials Regulation after Brexit. It is hoped this letter will be published in the national press in the near future.
See below to read.
2017 Summer School
The 2017 ICPV Summer School was held over two days in June at Stirling University. The theme of the event was Cancer Survivorship and Living Well Cancer. Click below for details of the course. More details.
A snapsot video of the the 2016 course is now available on YouTube VOICE2016
At the BACR/ECMC conference in July Maggie Wilcox and Mairead Mackenzie were persuaded to speak to the camera. Maggie gave a background to ICPV and our aims and objectives. While Mairead focused on her specific interests and activities. To view follow the links below.
July 2016 Conferences
ICPV members were busy this week with two conferences. The BACR/ECMC Joint Meeting on Therapeutic Interventions for Cancer Prevention was held in Bristol July18-19. The UK Breast Cancer Research Symposium was held in London from July 22-23. Click here for more information.
UK Therapeutic Cancer Prevention Network (UKTCPN)
An update from this new group was presented to the ECMC Annual Network Meeting in May 2016. Click here to download and read.
Call for immediate change to European Paediatric Medicine Regulation to save more lives of children and teens with cancer.
A few basic changes to European Law could speed up access to newer, kinder and potentially better drugs for more children and teenagers with cancer. Click to Sign the petition
Two years on from the start pioneering TRACERx lung cancer study. Click here For the latest news and patient views on this study.